Biotech · Private company · Chapel Hill, NC, US
Persistence Therapeutics, Inc.
Track this companyFree. Adds Persistence Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- The SynthNode Paradigm: Reimagining CAR T Cell Therapy for Improved Patient OutcomesFiscal year 2026 · $818.8KNIH RePORTER 4R44CA310319-02 · fetched Nov 12, 2026
- The SynthNode Paradigm: Reimagining CAR T Cell Therapy for Improved Patient OutcomesFiscal year 2025 · $314.7KNIH RePORTER 1R44CA310319-01 · fetched Nov 12, 2026